Receipt of notification from a shareholder under Article 69 of the Act on Public Offering
Current Report No. 7/2019
Date: 22 March 2019
Legal basis: Article 70 (1) of the Act on Public Offering – acquisition or disposal of a significant stake
The Management Board of Medicalgorithmics S.A. (“Company”, “Issuer”) announces that on 22 March 2019 the Company received a notification from Powszechne Towarzystwo Emerytalne PZU S.A. (“PTE PZU”) acting on behalf of Otwarty Fundusz Emerytalny PZU “Złota Jesień” (“OFE PZU”) pursuant to Article 69(1)(1) of the Act of 29 July 2005 on public offering and terms and conditions governing the introduction of financial instruments into organised trading and public limited companies (consolidated text: Journal of Laws of 2018, item 512 as amended) (“Act on Public Offering”).
PTE PZU notifies that as a result of completing the purchase of 5 250 (five thousand two hundred and fifty) shares of the Issuer on the Warsaw Stock Exchange on 19 March 2019, after settling the transaction on 21 March 2019, OFE PZU currently holds more than 10% of the total number of votes in the Company.
Before closing the transaction, OFE PZU held 360,158 shares of the Company, representing 9.99% of the Company’s share capital and 360,158 votes at the Company’s general meeting, constituting 9.99% of the total number of votes at the general meeting.
After closing the transaction, OFE PZU holds 365,408 shares of the Company, representing 10.13% of the Company’s share capital and 365,408 votes at the Company’s general meeting, constituting 10.13% of the total number of votes at the general meeting.
OFE PZU communicated that:
- it does not have any subsidiaries holding shares of the Company;
- the situation referred to in Article 69(4)(6) of the Act on Public Offering has not taken place,
- it does not hold any financial instruments referred to in Article 69b(1) items (1) and (2) of the Act on Public Offering.